Denali Therapeutics Inc.
Records under this name other than the patents Denali Therapeutics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 57 patents it holds.
Back to Denali Therapeutics Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,124,562 | Anti-Apoe Antibodies now held by Washington University In force · High confidence | In force | High confidence | |
| 15/240,419 | Oxadiazine Compounds and Methods of Use Thereof Abandoned Abandoned Apr 27, 2018 | Abandoned | Abandoned Apr 27, 2018 | |
| 15/624,566 | Compounds, Compositions, and Methods Abandoned Abandoned Jan 16, 2018 | Abandoned | Abandoned Jan 16, 2018 | |
| 16/312,172 | Albumin Variants for Enhanced Serum Half-Life Abandoned Abandoned Jun 14, 2023 | Abandoned | Abandoned Jun 14, 2023 | |
| 16/616,241 | Compounds, Compositions and Methods Abandoned Abandoned Feb 8, 2022 | Abandoned | Abandoned Feb 8, 2022 | |
| 16/646,536 | ANTI-TREM2 Antibodies and Methods of Use Thereof Abandoned Abandoned Sep 28, 2025 | Abandoned | Abandoned Sep 28, 2025 | |
| 16/649,943 | Fusion Proteins Comprising Enzyme Replacement Therapy Enzymes Abandoned Abandoned May 12, 2021 | Abandoned | Abandoned May 12, 2021 | |
| 16/782,446 | Compounds, Compositions and Methods Abandoned Abandoned Apr 5, 2021 | Abandoned | Abandoned Apr 5, 2021 | |
| 16/782,669 | Engineered Transferrin Receptor Binding Polypeptides Abandoned Abandoned Mar 19, 2024 | Abandoned | Abandoned Mar 19, 2024 | |
| 16/782,984 | Affinity-Based Methods for Using Transferrin Receptor-Binding Proteins Abandoned Abandoned Apr 10, 2023 | Abandoned | Abandoned Apr 10, 2023 |